plerixafor has been researched along with Medulloblastoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Arja, R; Bhunia, N; Dalal, JD; Goyal, RK; Kang, HJ; Lee, AC; Loeb, DM; Mehyar, LS; O'Brien, TA; Ozkaynak, MF; Rangarajan, HG; Roberts, CH; Shaw, PJ; Shenoy, SS; Stanek, JR; Stein, J; Strahlendorf, C | 1 |
| Cho, YJ; Liu, J; MacDonald, TJ; Rubin, JB; Schniederjan, M; Shu, HK; Yuan, L; Zhang, H | 1 |
| Cohen, IJ; Stein, J; Toledano, H; Yahel, A; Yaniv, I | 1 |
| Cardenoux, C; Deméocq, F; Kanold, J; Merlin, E; Oudot, C; Piguet, C; Roussanne, MC | 1 |
| Aabideen, K; Anoop, P; Ethell, ME; Potter, MN | 1 |
| Chan, JA; Kieran, MW; Klein, RS; Kung, AL; Luster, AD; Rubin, JB; Schmidt, K; Segal, RA; Sun, Y | 1 |
6 other study(ies) available for plerixafor and Medulloblastoma
| Article | Year |
|---|---|
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.
Topics: Adolescent; Antigens, CD34; Benzylamines; Blood Component Removal; Child; Child, Preschool; Cohort Studies; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Humans; Infant; Lymphoma; Male; Medulloblastoma; Neoplasms; Neuroblastoma; Peripheral Blood Stem Cells; Retrospective Studies; Sarcoma; Young Adult | 2021 |
Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.
Topics: Benzylamines; Cell Line, Tumor; Cell Movement; Cerebellar Neoplasms; Chemokine CXCL12; Cyclams; G-Protein-Coupled Receptor Kinases; Gene Expression; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Heterocyclic Compounds; Humans; Medulloblastoma; Platelet-Derived Growth Factor; Proteasome Endopeptidase Complex; Proteolysis; Receptor, Platelet-Derived Growth Factor alpha; Receptors, CXCR4; Signal Transduction; src-Family Kinases | 2013 |
Successful mobilization, harvest and transplant of peripheral blood stem cells using AMD3100 and G-CSF following high dose craniospinal irradiation for medulloblastoma in a young child.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Benzylamines; Cerebellar Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Medulloblastoma; Peripheral Blood Stem Cell Transplantation; Receptors, CXCR4 | 2010 |
Pegfilgrastim plus AMD 3100 for stem-cell mobilization in children.
Topics: Benzylamines; Cerebellar Neoplasms; Child; Cyclams; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Medulloblastoma; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins | 2010 |
The feasibility of plerixafor as a second-line stem cell mobilizing agent in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Child; Child, Preschool; Cyclams; Drug-Related Side Effects and Adverse Reactions; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Medulloblastoma; Neoplasm Staging; Wilms Tumor | 2011 |
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.
Topics: Animals; Anti-HIV Agents; Apoptosis; Benzylamines; Brain Neoplasms; Cell Division; Cell Line, Tumor; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Cyclams; Glioblastoma; Heterocyclic Compounds; Humans; In Situ Nick-End Labeling; Luciferases; Magnetic Resonance Imaging; Medulloblastoma; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Time Factors | 2003 |